Phosphinylidene compounds R(1)R(2)P(O)H are important functionalities in organophosphorus chemistry and display prototropic tautomerism. Quantifying the tautomerization rate is paramount to understanding these compounds' tautomerization behavior, which may impact their reactivities in various reactions. We report a combined theoretical and experimental study of the initial tautomerization rate of a range of phosphinylidene compounds. Initial tautomerization rates are found to decrease in the order H3PO2 > Ph2P(O)H > (PhO)2P(O)H > PhP(O) (OAlk)H > AlkP(O)(OAlk)H ≈ (AlkO)2P(O)H, where "Alk" denotes an alkyl substituent. The combination of computational investigations with experimental validation establishes a quantitative measure for the reactivity of various phosphorus compounds, as well as an accurate predictive tool.

Collision cross-section (CCS) measurements obtained from ion mobility spectrometry-mass spectrometry (IMS-MS) analyses often provide useful information concerning a protein’s size and shape and can be complemented by modeling procedures. However, there have been some concerns about the extent to which certain proteins maintain a native-like conformation during the gas-phase analysis, especially proteins with dynamic or extended regions. Here we have measured the CCSs of a range of biomolecules including non-globular proteins and RNAs of different sequence, size, and stability. Using traveling wave IMS-MS, we show that for the proteins studied, the measured CCS deviates significantly from predicted CCS values based upon currently available structures. The results presented indicate that these proteins collapse to different extents varying on their elongated structures upon transition into the gas-phase. Comparing two RNAs of similar mass but different solution structures, we show that these biomolecules may also be susceptible to gas-phase compaction. Together, the results suggest that caution is needed when predicting structural models based on CCS data for RNAs as well as proteins with non-globular folds. Graphical Abstractᅟ Electronic supplementary materialThe online version of this article (doi:10.1007/s13361-017-1689-9) contains supplementary material, which is available to authorized users.

We herein showcase the ability of NHC‐coordinated dinuclear NiI–NiI complexes to override fundamental reactivity limits of mononuclear (NHC)Ni0 catalysts in cross‐couplings. This is demonstrated with the development of a chemoselective trifluoromethylselenolation of aryl iodides catalyzed by a NiI dimer. A novel SeCF3‐bridged NiI dimer was isolated and shown to selectively react with Ar−I bonds. Our computational and experimental reactivity data suggest dinuclear NiI catalysis to be operative. The corresponding Ni0 species, on the other hand, suffers from preferred reaction with the product, ArSeCF3, over productive cross‐coupling and is hence inactive.

H-Phosphinates react with alkenes and alkynes using catalytic manganese(II) acetate. Under stoichiometric conditions with manganeseA C H T U N G T R E N N U N G (III) acetate or with catalytic manganese(II) acetate + excess manganese(II) oxide various reactions like arylation or cyclization through radical oxidative arylation can take place. Whereas the chemistry of manganese is already well developed for the functionalization of H-phosphonates, the present methodology provides an unprecedented access to functionalized phosphinates in acceptable to good yields.

The room-temperature hydrophosphinylation of unactivated monosubstituted alkenes using phosphinates (ROP(O)H2) and catalytic NiCl2 in the presence of dppe is described. The method is competitive with prior palladium-catalyzed reactions and uses a much cheaper catalyst and simple conditions. The scope of the reaction is quite broad in terms of unactivated terminal olefins, proceeds at room temperature, often avoids chromatographic purification, and allows one-pot conversion to various organophosphorus compounds.

Computational studies receive increased attention in the mechanistic exploration of transition metal catalyzed reactions. Especially in Pd catalysis, numerous mechanistic insights could be gained by the use of computational tools to complement experimental studies in order to provide a more detailed mechanistic picture. This includes not only the exploration of novel mechanistic scenarios, but also the comparison of different plausible reaction pathways. The current intense use of calculations in mechanistic studies of Pd-catalyzed reactions has encouraged constant advancements in the field. However, a number of challenges will be faced in the computational treatment of Pd reactivities, including tackling conformational space, charged molecules, varying ligation states and the description of complexes bearing multiple Pd centers. Their careful consideration may enrich the mechanistic picture of numerous Pd-catalyzed reactions, but may also encourage further development of computational methodology.

Hepatitis B virus (HBV) is a major human pathogen that causes serious liver disease and 600,000 deaths annually. Approved therapies for treating chronic HBV infections usually target the multifunctional viral polymerase (hPOL). Unfortunately, these therapies-broad-spectrum antivirals-are not general cures, have side effects, and cause viral resistance. While hPOL remains an attractive therapeutic target, it is notoriously difficult to express and purify in a soluble form at yields appropriate for structural studies. Thus, no empirical structural data exist for hPOL, and this impedes medicinal chemistry and rational lead discovery efforts targeting HBV. Here, we present an efficient strategy to overexpress recombinant hPOL domains in Escherichia coli, purifying them at high yield and solving their known aggregation tendencies. This allowed us to perform the first structural and biophysical characterizations of hPOL domains. Apo-hPOL domains adopt mainly ␣-helical structures with small amounts of ␤-sheet structures. Our recombinant material exhibited metal-dependent, reverse transcriptase activity in vitro, with metal binding modulating the hPOL structure. Calcomine orange 2RS, a small molecule that inhibits duck HBV POL activity, also inhibited the in vitro priming activity of recombinant hPOL. Our work paves the way for structural and biophysical characterizations of hPOL and should facilitate high-throughput lead discovery for HBV. IMPORTANCEThe viral polymerase from human hepatitis B virus (hPOL) is a well-validated therapeutic target. However, recombinant hPOL has a well-deserved reputation for being extremely difficult to express in a soluble, active form in yields appropriate to the structural studies that usually play an important role in drug discovery programs. This has hindered the development of muchneeded new antivirals for HBV. However, we have solved this problem and report here procedures for expressing recombinant hPOL domains in Escherichia coli and also methods for purifying them in soluble forms that have activity in vitro. We also present the first structural and biophysical characterizations of hPOL. Our work paves the way for new insights into hPOL structure and function, which should assist the discovery of novel antivirals for HBV. Hepatitis B virus (HBV) is a highly infectious, species-specific pathogen that causes serious liver diseases, including cancer, and causes 600,000 deaths annually (1). While excellent prophylactic HBV vaccines exist, these are ineffective against extant chronic HBV infections which affect 350 million people worldwide. Approved therapies for chronic HBV infections include immuno-modulators (e.g., interferon therapies) and nucleoside analogues that inhibit the reverse transcriptase domain of hPOL, the multifunctional viral polymerase of human HBV. These reverse transcriptase inhibitors, currently our best weapons against HBV, are not complete cures and have unwanted side effects (2, 3). While reverse transcriptase inhibitors are initially very effective at...

No abstract